LPIN1 and glioblastoma: In mouse myoblast C2C12 and human primary glioblastoma U87 cells, LPIN1 siRNA achieved > 70% knockdown efficiency, resulting in abnormal expression levels of muscular and neuronal markers (Figure 7G, H).